A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
Pfizer no longer going to conduct interim analysis for Duchenne gene therapy study by end of year
Pfizer no longer plans to read out an interim analysis on its Duchenne muscular dystrophy gene therapy program by the end of the year, it
December 20, 2023